Abstract:Aim: To study the differentiation of mesenchymal stem cells (MSCs) from rabbit bone marrow in different tomite murine cardiac myocytes microenvironment in vitro, and to establish a new cell source of cell transplantation for cardiovascular diseases. Methods: Rabbit MSCs were isolated and cultured in vitro. After induced by 5-azacytidine, MSCs were co-cultured with normal or damaged tomite murine cardiac myocytes, which had been cultured in adriamycin (ADR), in Millicell culture device (normal group and ADR group). On the 14th, 21st and 28th days after co-culture, MSCs were identified by means of immunochemistry techniques and RT-PCR. And the percent of cells, which were positive expression of α-sarcomeric actin, in different groups was detected by flow cytometer. MSCs induced only by 5-azacytidine were regarded as the control group. Results: On the 14th day, only a few cells in the normal group were staining for α-sarcomeric actin, connexin-43; and positive cells were detected in all the three groups on the 21st, 28th day. The expressions of α-skeletal actin and α-cardiac actin could be detected by RT-PCR. But the percent of positive cells in the normal group was larger than those in the control and ADR groups. Conclusion: MSCs are a group of stem cells in the bone marrow, with the capacity of differentiating into multiple mesenchymal lineages. They can differentiate into cardiac myoid cells in normal and pathological cardiac myocyte microenvironment in vitro, and microenvironment can promote the differentiation. MSCs may be a new cell source of cell transplantation in cardiovascular diseases therapy.

Ideal material for the transplantation of cardiovascular disease:experimental study on differentiation of mesenchymal stem cells in different cardiac myocytes microenvironment in vitro